跳至主要内容
临床试验/CTRI/2016/11/007455
CTRI/2016/11/007455招募中4 期

A prospective, single arm, multi-centre, observational, real world, post marketing surveillance to evaluate implant survivorship and performance of the Freedom® Total Knee System in total knee arthroplasty. - Freedom® 400

Meril Life Sciences India Pvt Ltd0 个研究点目标入组 400 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1.Subject is male or non-pregnant female
  • aged 18 years or older at the time of
  • 2.Subject is willing and able to provide
  • written Informed Consent by signing and
  • dating the IRB or EC approved Informed
  • Consent Form.
  • 3.Subject is a candidate for a total knee
  • arthroplasty
  • 4.Subject is willing and able to comply
  • with postoperative scheduled clinical and
  • radiographic evaluations

排除标准

  • 1.Subject with a BMI greater than or equal
  • 2.Subject with an active infection within
  • the affected knee joint
  • 3.Subject with neuromuscular or
  • neurosensory deficiency that may limit
  • ability of the patient to evaluate the
  • safety and efficacy of the device
  • 4.Subject with a known sensitivity to
  • device materials
  • 5.Subject is unwilling or unable to sign
  • the Informed Consent Document.
  • 6.Subject with short Life expectancy less
  • than 5 years (e.g. Cancer, HIV/AIDS)
  • 7.Subject with history of deep vein
  • thrombosis or other thrombotic disorders.
  • 8.Subject with conditions such as
  • Parkinsonism, loco motors ataxia, spinal
  • scoliosis or kyphosis, stroke etc. that
  • would affect their loco motors stability
  • and interfere with assessment of Range of
  • Motion of the target Knee.
  • 9.Subject who, in consideration of treating
  • doctor, would not be suitable for
  • compliance of the follow up

研究者

发起方
Meril Life Sciences India Pvt Ltd

相似试验